Aurinia Pharmaceuticals Inc.
AUPH
$12.27
$0.191.57%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 12.08% | 4.34% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 12.08% | 4.34% | |||
| Cost of Revenue | 1.61% | 4.82% | |||
| Gross Profit | 15.19% | 4.20% | |||
| SG&A Expenses | 27.92% | -45.08% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | 108.76% | 217.72% | |||
| Total Operating Expenses | 27.44% | -24.96% | |||
| Operating Income | -13.61% | 200.44% | |||
| Income Before Tax | -9.01% | 1,975.79% | |||
| Income Tax Expenses | -36.02% | 492.58% | |||
| Earnings from Continuing Operations | -7.84% | 1,533.59% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -7.84% | 1,533.59% | |||
| EBIT | -13.61% | 200.44% | |||
| EBITDA | -11.24% | 123.32% | |||
| EPS Basic | -5.06% | 1,563.37% | |||
| Normalized Basic EPS | -11.34% | 60.33% | |||
| EPS Diluted | -0.31% | 1,484.16% | |||
| Normalized Diluted EPS | -10.44% | 61.66% | |||
| Average Basic Shares Outstanding | -2.91% | -2.29% | |||
| Average Diluted Shares Outstanding | -3.96% | -3.03% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||